2 min read
How to Design an Efficient Preclinical Testing Study
A medical device’s pathway from concept to commercialization can be fraught with pitfalls, setbacks, and a need to recurring, significant...
1 min read
admin.veranex : Sep 9, 2024 10:10:41 AM
When it comes to kicking off your preclinical study, assembling the right team will help you anticipate challenges and implement solutions that will help your study progress efficiently, saving you time and resources. In this blog post, we lay out the primary roles you will interact with during this phase of your product’s development.
Sponsor
The medical product developer
Initiates and supports a non-clinical laboratory study and submits the study in support of an application for a research or marketing permit
Range from large, publicly traded companies to startups to individual innovators
Study Director/Principal Investigator/Program Manager
Scientists with proven capabilities of successfully coordinating and leading preclinical studies, often with significant experience in at least one or two therapeutic areas
Overall responsibility for the technical conduct of the study as well as for the interpretation, analysis, documentation, and reporting of results
Represents a single point of study control
Principal investigator plays a similar role, but for a contributing scientist report or non-GLP study
Quality Assurance
Trained professionals that independently monitor the execution of a preclinical GLP study
Assure compliance with the protocol and test facility SOPs
Responsible for monitoring the study to assure test facility management that the facilities, equipment, personnel, methods, practices, records, and controls are in compliance with regulations
Veterinarian / Veterinary Personnel
Ensures adherence to USDA, AAALAC, and animal welfare guidelines
Clinical Expert/Key Opinion Leader
Leverage to speed up product development and approval pathway
Contributing Scientists
Multiple members either from the sponsor’s team, the preclinical CRO’s team, or other facility or lab staff and/or independent subject matter experts. Includes engineers, chemists, imaging, histopathology, clinical pathology, etc.
Let's Meet the Challenges of Medical Device Innovation, Including Preclinical Testing,Together.
What preclinical challenges are you facing? We know medical device innovation is challenging at every level, in every phase. Veranex has end-to-end resources with expertise throughout the commercialization process from the earliest phases like market assessment, human factors and design through regulatory submission, quality control, manufacturing and market access. This ensures wherever you are, you don't have to stop work when "downstream" expertise is needed to inform the work being done today.
Our industry leading preclinical CRO services have supported over 100 regulatory submissions returned with no questions asked.
2 min read
A medical device’s pathway from concept to commercialization can be fraught with pitfalls, setbacks, and a need to recurring, significant...
5 min read
Atrial fibrillation remains a leading cause of death and disability and the most common type of arrhythmia. While radiofrequency ablation and...
4 min read
When it comes to meeting deadlines and continuing to receive investments, the timely review of your GLP preclinical final report is very...